Results 121 to 130 of about 2,196 (157)

Dyslipidemia in asthma: Treatable trait, or just a common comorbidity? [PDF]

Chin Med J (Engl)
Deng K, Wang J, Oliver BG, Wood LG, Wang G.   +4 more
europepmc   +1 more source

Apolipoprotein A (ApoA) in Neurological Disorders: Connections and Insights. [PDF]

Int J Mol Sci
Rajha HE, Hassanein A, Mesilhy R, Nurulhaque Z, Elghoul N, Burgon PG, Al Saady RM, Pedersen S.   +7 more
europepmc   +1 more source

Comparison of cholesterol transport capacity of peptide- and polymer-based lipid Nanodiscs. [PDF]

Nanomedicine
Yu M, Vaishnav S, Dorsey KH, Phoo MT, Rodriguez A, Schwendeman A.   +5 more
europepmc   +1 more source

The distinct properties of high-density lipoprotein nanoparticles as ocular drug delivery vehicles. [PDF]

Nanomedicine (Lond)
Murakami T, Kurita H.
europepmc   +1 more source

Mechanisms of high-density lipoprotein in regulating blood-brain barrier function: insights and implications. [PDF]

Fluids Barriers CNS
Zhu P, Xiao L, Wang Y.
europepmc   +1 more source

Expanding the Reach of Membrane Protein-Ligand Interaction Studies Through the Integration of Mass Spectrometry and Membrane Mimetics. [PDF]

Proteomics
Lambos JC, Bhattacharya A, Al-Seragi M, Duong van Hoa F.   +3 more
europepmc   +1 more source

Protective Effects of COG133 on Carbon Tetrachloride-Induced Acute Liver Injury: Modulation of Inflammation, Apoptosis and Sphingolipid Metabolism. [PDF]

J Cell Mol Med
Aslan M, Çırçırlı B, Öztüzün A, Tuzcu H, Yılmaz Ç, Çeker T, Elpek GÖ.   +6 more
europepmc   +1 more source

HDL in Abdominal Aortic Aneurysm: Mechanistic Insight and Therapeutic Potential. [PDF]

Curr Atheroscler Rep
Catalano JC, Guo Y, Bordeau BM, Yu M, Schwendeman A.   +4 more
europepmc   +1 more source

The Structural and Functional Journey of Apolipoprotein A-I Through the Human Body. [PDF]

Curr Atheroscler Rep
Powell SM, You Y, Ogbu CP, Melchior JT.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Apolipoprotein A-I-mimetic peptides with antioxidant actions

Archives of Biochemistry and Biophysics, 2006
To augment antioxidant action of apolipoprotein A-I (Apo A-I)-mimetic peptide, the peptide F3,6,14,18 18A (DWFKAFYDKVAEKFKEAF) was modified by incorporating antioxidant amino acid residues. Introduction of His residue at position 2 or 3 at N-terminal of the peptide remarkably enhanced antioxidant action against Cu2+ oxidation of LDL and the capability ...
Tae-Sook Jeong, Dai-Eun Sok, Su Duy Nguyen   +2 more
exaly   +3 more sources